Cargando…
Oncolytic Activity of a Recombinant Measles Virus, Blind to Signaling Lymphocyte Activation Molecule, Against Colorectal Cancer Cells
Oncolytic virotherapy is a distinctive antitumor therapy based on the cancer-cell-specific infectivity and killing activity of viruses, which exert a considerable antitumor effect with only a few treatments. Because colorectal cancer cells often acquire resistance to the molecular-targeted therapies...
Autores principales: | Amagai, Yosuke, Fujiyuki, Tomoko, Yoneda, Misako, Shoji, Koichiro, Furukawa, Yoichi, Sato, Hiroki, Kai, Chieko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835780/ https://www.ncbi.nlm.nih.gov/pubmed/27090874 http://dx.doi.org/10.1038/srep24572 |
Ejemplares similares
-
Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin‐4‐expressing pancreatic cancer cells
por: Awano, Mutsumi, et al.
Publicado: (2016) -
A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells
por: Fujiyuki, Tomoko, et al.
Publicado: (2015) -
Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy
por: Fujiyuki, Tomoko, et al.
Publicado: (2020) -
Development of new therapy for canine mammary cancer with recombinant measles virus
por: Shoji, Koichiro, et al.
Publicado: (2016) -
Immune response elicited in the tumor microenvironment upon rMV‐SLAMblind cancer virotherapy
por: Moritoh, Kanako, et al.
Publicado: (2023)